Tag: #Global Trends

The European Commission (EC) has granted marketing authorization for Otsuka’s Dawnzera (donidalorsen) for the routine prevention of recurrent attacks in... Read more

China has transitioned from having one of the world's most sluggish drug approval systems to one of the fastest. This... Read more

Medical technology leaders BD (Becton, Dickinson and Company) and Ypsomed have expanded their ongoing collaboration by introducing a new 5.5mL... Read more

Responding to the rise of at-home patient care, Datwyler has launched a first-to-market universal plunger designed for large-volume cartridges of... Read more

Novo Nordisk and Aspect Biosystems have entered a new phase of their collaboration aimed at developing curative cell-based medicines for... Read more

Amid expanding measles outbreaks across several states, a top official at the Centers for Disease Control and Prevention (CDC) suggested... Read more

On January 20, 2026, Corvus Pharmaceuticals saw its stock price nearly triple following the release of Phase 1 clinical trial... Read more

In its financial report released January 21, 2026, Johnson & Johnson (J&J) set an ambitious target for the upcoming year,... Read more

Novavax and Pfizer have announced a non-exclusive licensing agreement, marking a pivotal strategic shift for Novavax in 2026. Under the... Read more